UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 6, 2004
CardioDynamics International Corporation
(Exact name of registrant as specified in its charter)
California 0-11868 95-3533362
-------------------------------------------------------------------------------
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
6175 Nancy Ridge Drive, San Diego, California 92121
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (858) 535-0202
--------------
n/a
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events:
Exhibit filed with this report:
Exhibit 99. Registrant's press release dated April 6,
2004 announcing seven peer-reviewed journal articles that further
validate CardioDynamics' clinical application in heart failure.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
CARDIODYNAMICS
INTERNATIONAL CORPORATION
Date: April 6, 2004 By: /s/ Stephen P. Loomis
--------------------------
Stephen P. Loomis
Chief Financial Officer